<DOC>
	<DOCNO>NCT02016183</DOCNO>
	<brief_summary>To evaluate safety efficacy long-term use candesartan cilexetil / hydrochlorothiazide combination tablet ( ECARD ) Combination Tablets LD &amp; HD hypertensive patient routine clinical setting</brief_summary>
	<brief_title>Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance : Long-term Use ( 12 Months )</brief_title>
	<detailed_description>This special drug use surveillance long-term use candesartan cilexetil / hydrochlorothiazide combination tablet ( ECARD combination tablet ) evaluate hypertensive patient routine clinical setting . Because drug contains diuretic ( hydrochlorothiazide ) , necessary ass safety , especially serum uric acid . ( planned sample size 3000 ) . The usual adult dosage 1 tablet ( 4 mg/6.25 mg 8 mg/6.25 mg candesartan cilexetil/hydrochlorothiazide ) administer orally daily . This drug use first-line drug hypertension treatment .</detailed_description>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Hypertensive patient ( 1 ) Patients history hypersensitivity ingredient ECARD LD &amp; HD combination tablet , thiazide , analogue ( e.g . sulphonamide derivative chlortalidone ) ( 2 ) Patients anuria patient hemodialysis ( 3 ) Patients acute renal failure ( 4 ) Patients noticeably decrease Na K level body fluid ( 5 ) Pregnant woman woman plan become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>